Work

An Adult Case of Chest Wall Langerhans Cell Histiocytosis Mimicking Malignancy and Responding to Targeted Therapy

Year: 2026

Type: article

Abstract: Langerhans cell histiocytosis (LCH) is a rare clonal proliferation of dendritic cells that is exceptionally uncommon in adults and only rarely affects the chest wall. Adult rib lesions often radiographically mimic malignancy, necessitating biopsy for accurate diagnosis. We report the case of a 52-year-old woman with Class III (severe) obesity and newly diagnosed type 2 diabetes who developed a painful right chest wall mass following severe coughing during coronavirus disease 2019 (COVID-19). Imaging revealed a lobulated lesion with rib erosion and pleural indentation concerning for malignancy. Surgical debridement yielded histiocytic inflammation, and cultures grew Staphylococcus epidermidis. Final histopathology confirmed LCH. Despite wound re-closures and antibiotic therapy, persistent drainage continued until molecular testing identified a B-Raf proto-oncogene, serine/threonine-protein kinase (BRAF) V600E mutation. Targeted therapy with dabrafenib and trametinib was initiated, resulting in rapid clinical improvement and complete wound healing. Adult chest wall LCH represents a rare diagnostic challenge due to its malignant radiographic appearance. Histopathologic confirmation, with molecular testing, is essential, and targeted BRAF/mitogen-activated protein kinase kinase (MEK) inhibition may provide an effective therapeutic option when conventional measures fail.

Source: Cureus

DOI: 10.7759/cureus.100949

Authors: Michael W Alchaer, Trina Capelli, Thomas A Abbruzzese, Alene Wright

Institutions: University of South Florida, HCA Healthcare

Language: English

Topic: Histiocytic Disorders and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: HCA Healthcare